IRIS Accounts Production v23.3.1.45 08506049 Board of Directors 1.6.22 31.12.22 31.12.22 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh085060492022-05-31085060492022-12-31085060492022-06-012022-12-31085060492021-05-31085060492021-06-012022-05-31085060492022-05-3108506049ns10:Originalns15:EnglandWales2022-06-012022-12-3108506049ns14:PoundSterlingns10:Original2022-06-012022-12-3108506049ns10:Originalns10:Director12022-06-012022-12-3108506049ns10:Original2022-06-012022-12-3108506049ns10:Original2022-12-3108506049ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012022-12-3108506049ns10:Originalns10:SmallEntities2022-06-012022-12-3108506049ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012022-12-3108506049ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012022-12-3108506049ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012022-12-3108506049ns10:Originalns10:FullAccounts2022-06-012022-12-3108506049ns10:Originalns10:OrdinaryShareClass12022-06-012022-12-3108506049ns10:Originalns10:Director22022-06-012022-12-3108506049ns10:Originalns10:Director32022-06-012022-12-3108506049ns10:Originalns10:Director42022-06-012022-12-3108506049ns10:Originalns10:RegisteredOffice2022-06-012022-12-3108506049ns10:Original2022-05-3108506049ns10:Originalns5:CurrentFinancialInstruments2022-12-3108506049ns10:Originalns5:CurrentFinancialInstruments2022-05-3108506049ns10:Originalns5:Non-currentFinancialInstruments2022-12-3108506049ns10:Originalns5:Non-currentFinancialInstruments2022-05-3108506049ns5:ShareCapitalns10:Original2022-12-3108506049ns5:ShareCapitalns10:Original2022-05-3108506049ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3108506049ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3108506049ns10:Originalns5:LeaseholdImprovements2022-06-012022-12-3108506049ns10:Originalns5:FurnitureFittings2022-06-012022-12-3108506049ns10:Originalns5:MotorVehicles2022-06-012022-12-3108506049ns10:Originalns5:ComputerEquipment2022-06-012022-12-3108506049ns10:Original2021-06-012022-05-3108506049ns10:Originalns5:LeaseholdImprovements2022-05-3108506049ns10:Originalns5:FurnitureFittings2022-05-3108506049ns10:Originalns5:MotorVehicles2022-05-3108506049ns10:Originalns5:ComputerEquipment2022-05-3108506049ns10:Original2022-05-3108506049ns10:Originalns5:LeaseholdImprovements2022-12-3108506049ns10:Originalns5:FurnitureFittings2022-12-3108506049ns10:Originalns5:MotorVehicles2022-12-3108506049ns10:Originalns5:ComputerEquipment2022-12-3108506049ns10:Originalns5:LeaseholdImprovements2022-05-3108506049ns10:Originalns5:FurnitureFittings2022-05-3108506049ns10:Originalns5:MotorVehicles2022-05-3108506049ns10:Originalns5:ComputerEquipment2022-05-3108506049ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3108506049ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-3108506049ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-12-3108506049ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-05-3108506049ns10:Originalns10:OrdinaryShareClass12022-12-3108506049ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3108506049ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-012022-12-31
REGISTERED NUMBER: 08506049 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 JUNE 2022 TO 31 DECEMBER 2022

FOR

HARVEY MEDICAL CONSULTING LIMITED

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JUNE 2022 TO 31 DECEMBER 2022










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


HARVEY MEDICAL CONSULTING LIMITED

COMPANY INFORMATION
FOR THE PERIOD 1 JUNE 2022 TO 31 DECEMBER 2022







DIRECTORS: Mrs Beatrice Louisa Harvey
Mr Joshua Boylan
Ms Kelley Henderson
Mr Xin Zhang





REGISTERED OFFICE: Copley Hill Business Park, Lower Court 6
Suites A, B and C
Cambridge Road, Babraham
Cambridge
CB22 3AF





REGISTERED NUMBER: 08506049 (England and Wales)





ACCOUNTANTS: Syers McGill
9 Kerry Street
Horsforth
Leeds
West Yorkshire
LS18 4AW

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

BALANCE SHEET
31 DECEMBER 2022

31.12.22 31.5.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 6,561 40,399

CURRENT ASSETS
Stocks 68,530 65,602
Debtors 5 210,699 167,746
Cash at bank 61,257 139,201
340,486 372,549
CREDITORS
Amounts falling due within one year 6 109,259 108,204
NET CURRENT ASSETS 231,227 264,345
TOTAL ASSETS LESS CURRENT
LIABILITIES

237,788

304,744

CREDITORS
Amounts falling due after more than one
year

7

-

30,833
NET ASSETS 237,788 273,911

CAPITAL AND RESERVES
Called up share capital 8 1 1
Retained earnings 9 237,787 273,910
SHAREHOLDERS' FUNDS 237,788 273,911

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2022.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

BALANCE SHEET - continued
31 DECEMBER 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 November 2023 and were signed on its behalf by:





Mr Xin Zhang - Director


HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 JUNE 2022 TO 31 DECEMBER 2022


1. STATUTORY INFORMATION

Harvey Medical Consulting Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - not provided
Fixtures and fittings - 25% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Work in progress is valued at the lower of cost and net realisable value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 7 (2022 - 6 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 June 2022 21,833 13,988 34,560 7,539 77,920
Additions - 3,138 - 647 3,785
Disposals (21,833 ) (11,420 ) (34,560 ) (483 ) (68,296 )
At 31 December 2022 - 5,706 - 7,703 13,409
DEPRECIATION
At 1 June 2022 - 10,797 22,131 4,593 37,521
Charge for period - 466 - 430 896
Eliminated on disposal - (9,187 ) (22,131 ) (251 ) (31,569 )
At 31 December 2022 - 2,076 - 4,772 6,848
NET BOOK VALUE
At 31 December 2022 - 3,630 - 2,931 6,561
At 31 May 2022 21,833 3,191 12,429 2,946 40,399

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 JUNE 2022 TO 31 DECEMBER 2022


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.22 31.5.22
£    £   
Trade debtors 191,812 156,051
Other debtors 5,895 11,695
Prepayments and accrued income 12,992 -
210,699 167,746

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.22 31.5.22
£    £   
Bank loans and overdrafts - 10,000
Tax 60,447 48,438
Social security and other taxes 12,844 5,036
VAT 26,978 44,259
Directors' current accounts - 71
Accrued expenses 8,990 400
109,259 108,204

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.22 31.5.22
£    £   
Bank loans - 30,833

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.22 31.5.22
value: £    £   
1 Ordinary £1 1 1

9. RESERVES
Retained
earnings
£   

At 1 June 2022 273,910
Profit for the period 10,377
Dividends (46,500 )
At 31 December 2022 237,787

10. RELATED PARTY DISCLOSURES

On 5 January 2023 Clarimed, Inc purchased the entire share capital of the company.